Concurrently, PSP suppresses hepatic glucose overproduction by transcriptionally downregulating gluconeogenesis-related genes, particularly Pck2 (phosphoenolpyruvate carboxykinase), thereby mitigating hyperglycemia. This evidence concerns the gene PCK2 and Hyperglycemia.